Citius Oncology Inc (CTOR)
0.94
-0.04
(-4.08%)
USD |
NASDAQ |
Dec 24, 16:00
Citius Oncology Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 275.17B |
| Citius Pharmaceuticals Inc | 6.875M |
| NovaBay Pharmaceuticals Inc | 1.919M |
| Palatin Technologies Inc | 16.97M |
| iBio Inc | 11.99M |